OTC Healthcare in Ukraine
Euromonitor International's OTC Healthcare in Ukraine market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 94 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC Healthcare increasingly profitable in value terms
In 2005, OTC Healthcare in Ukraine proved to be a highly profitable business, with sales rising by 10% in constant value terms. Rising prices did not scare consumers, and volume consumption even kept on growing as self-medication proliferated. Lower immunity of people, which is especially true of the young generation, resulted in higher illness incidence. On top of this, dissatisfaction with medical service levels at policlinics, the ability to get professional advice at chemists/pharmacies, and heavy advertising of medicines on TV, made Ukrainians rely on themselves in cases of minor, and even more serious, illnesses. Rising consumer income was a timely aid too, as people could spend more on medicines believed to be helpful to their health. This situation was assessed by the Ministry of Health as an alarm, signalling the over-involvement of Ukranians with OTC Healthcare medicines. As a result, there was an attempt to reduce the list of OTC Healthcare medicines significantly, and to impose stricter control on sales.
Vitamins and dietary supplements posits high dynamics
Over the review period, vitamins and dietary supplements led OTC Healthcare in Ukraine, positing the highest total value sales dynamics. More customers realised the importance of preventative medication. They preferred to avoid more serious health problems since lifestyles got busier and ‘no time to be ill’ became a slogan, especially with the young generation. To ensure the best effect, Ukrainians, unlike in many other OTC Healthcare sectors, did not economise on price in the case of vitamins and dietary supplements, being rather suspicious about cheap offerings. Multivitamins and minerals complexes got high attention as a result. Ginkgo biloba was one of the recent favourites.
Child-specific OTC healthcare welcomed
In 2005, child-specific OTC healthcare increased in prominence, with more attention paid to medicines developed especially for children. Since the number of children per family kept declining, parents were increasingly concerned about providing their kids with the best possible option. Naturally, reduced doses of adult medicines are not very appealing any more for children, as consumers believe that child-specific products have a better balance of active ingredients and embrace all the peculiarities of growing organisms. Considering the strongly underdeveloped status of the sector, child-specific OTC healthcare attracted more players and products.
Consolidation continues
In spite of the fragmented nature of OTC Healthcare in Ukraine, due to a significant number of companies competing, 2005 was noted by further consolidation. Leading manufacturers kept on strengthening their company value shares, actively investing in distribution, innovation development and brands building. A number of companies strengthened their positions through mergers and acquisitions abounding in 2004/05. Among domestic players, Halychpharm AT and Kyivmedpreparat VAT were the ones strengthening their positions significantly via merging into Arterium Corporation.
Forecast performance concomitant with overall economic development
OTC Healthcare is a promising sector over the forecast period in Ukraine, considering current low per capita consumption of medicines. However, economic factors are particularly important since consumer incomes and, hence, living standards of people will determine future value of consumer expenditure. In addition, the level of further healthcare system financing will either force people to turn to self-medication or grow more trusting in hospitals. The legislative base will determine OTC Healthcare consumption also, since switching might become more common. Under any conditions, innovations will serve as an efficient driving force of OTC Healthcare sales over the forecast period, especially if new product developments offer higher efficacy combined with naturalness of ingredients. Herbal-based medicines will be among the most attractive ones.
Table of contents
OTC HEALTHCARE IN UKRAINE : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 5 OTC Healthcare Switches 2004-2005
Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - UKRAINE
BORSCHAHIVSKY HFZ ZAT - OTC HEALTHCARE - UKRAINE
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Borschagivsky HFZ ZAT: Operational Indicators 2004
PRODUCTION CAPACITY
Summary 2 Summary - Borschagivsky HFZ ZAT: Production Statistics 2005
DARNITSA FF ZAT - OTC HEALTHCARE - UKRAINE
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - Darnitsa FF ZAT: Operational Indicators 2004
PRODUCTION CAPACITY
Summary 4 Summary - Darnitsa FF ZAT: Production Statistics 2005
FARMAK VAT - OTC HEALTHCARE - UKRAINE
COMPANY BACKGROUND
RECENT NEWS
Summary 5 Summary - Farmak VAT: Operational Indicators 2004
PRODUCTION CAPACITY
Summary 6 Summary - Farmak VAT: Production Statistics 2004
ZDOROVYA FK TOV - OTC HEALTHCARE - UKRAINE
COMPANY BACKGROUND
RECENT NEWS
Summary 7 Summary - Zdorovya FK TOV: Operational Indicators 2004
PRODUCTION CAPACITY
Summary 8 Summary - Zdorovya FF TOV: Production Statistics 2004
ANALGESICS IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
In 2005, analgesics revives although sector saturation restricts dynamic growth
Topical analgesics/anaesthetic – the highest growth subsector in 2005
Adult analgesics already established
Child-specific analgesics suffers from lack of assortment
Local manufacturers and foreign players mixed up – who wins in analgesics?
Forecast performance hampered by the sector’s maturity
Topical analgesics/anaesthetic a driving force for analgesics
Child-specific analgesics benefits with innovations to come
Adult analgesics’ saturation restricts forecast growth
Table 12 Sales of Analgesics by Subsector: Value 2000-2005
Table 13 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 14 Analgesics Company Shares by Retail Value 2001-2005
Table 15 Analgesics Brand Shares by Retail Value 2002-2005
Summary 9 Summary - Analgesics: New Product Launches 2004-2005
Table 16 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Analgesics offered as standard
Table 18 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
The sector gets strength in 2005, offsetting last year’s performance
A switch from herbal/traditional remedies to standard drugs increasingly characterises sector
Combination products – cough, cold and allergy (hay fever) remedies – the highest growth
Pharyngeal preparations driven by higher incidence of sore throats
Cough remedies benefits from growing consumer incomes
Medicated confectionery bears an image of standard confectionery
Antihistamines/allergy remedies (systemic) – strong Rx pressure
Top three – multinationals again
Forecast performance benefits from further branding
Child-specific cough, cold and allergy remedies in the lead
Cough remedies, pharyngeal preparations and combination products among most dynamic
Decongestants, medicated confectionery and antihistamines/allergy remedies (systemic) invite new product developments
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 10 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Herbal/Traditional varieties increasingly prioritised
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Convenience of use – a significant factor for consumer choice
Nasal sprays maintains the lead
Nasal decongestant drops – the oldest format
Decongestant rubs and inhalant decongestants invite innovations
Two new niches still welcome
Table 26 Sales of Decongestants by Type: Value 2000-2005
Table 27 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Child-specific products meet growing attention from parents
Table 28 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 29 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
Digestive remedies speeds up in 2005 –stronger consumer demand plays a role
Child-specific diarrhoeal remedies – Smecta afforded by more parents
IBS treatments suffers from poor OTC Healthcare medicines assortment
Indigestion and heartburn remedies hampered by Rx status
Diarrhoeal remedies – strong seasonality drive
Laxatives adores fatty diets
Motion sickness remedies awaits better times
Foreign manufacturers push locals below
Forecast sales strongly tied to economic development in Ukraine
Child-specific digestive remedies – the best performer as players are active in innovations
Indigestion and heartburn remedies faces Rx competition
Diarrhoeal remedies and laxatives witness shifting meals trends
IBS treatments in great need of OTC Healthcare innovations
Table 30 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 32 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 33 Digestive Remedies Brand Shares by Retail Value 2002-2005
Summary 11 Summary - Digestive Remedies: New Product Launches 2004-2005
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Herbal offerings traditionally appealing – the share continues to increase
Table 36 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
Other indigestion and heartburn remedies in demand due to higher digestive problems incidence
Antacids benefits from the widest products range and active promotion
Antiflatulents faces competition from products with complex effects
Digestive enzymes moves ahead – promotion proves efficient
Table 37 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 38 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
Medicated skin care posits better results compared to 2004 performance
Acne treatments – the highest growth subsector in 2005
Topical germicidals/antiseptics – the least innovations hamper sales
Antipruritics and topical allergy remedies/antihistamines largely Rx
Topical and vaginal antifungals and antiparasitics/lice (head and body) treatments suffer from taboos
Medicated shampoos and hair loss treatments too expensive, though prospects arise
Lip care treatments and emollients/therapeutic moisturisers see little development
Haemorrhoid treatments benefits from self-medication
Nappy (diaper) rash treatments and child-specific medicated skin care affected by declining birth rates
Shares fragmented due to a wide range of products available
Forecast performance slows down on the historic period – saturation matters
Acne treatments – the most dynamic performance
The ‘oldest’ versions restricted in sales movement
Table 39 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 40 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 41 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 42 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 12 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Herbal is traditional and hence popular
Table 45 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Multinational leadership maintained
Table 46 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Just a few compete
Table 47 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
Vitamins and dietary supplements speeds up in 2005, boosted by more upper-priced products purchased
Unit price on the rise in 2005, especially with value-added products
Vitamins by far the strongest in 2005
Dietary supplements poorly structured
Tonics and bottled nutritive drinks the least appealing – traditional tonics highly competitive
Child-specific vitamins and dietary supplements witnesses eventual quantitative changes
Multinationals dominate due to high prices and active brand support
Forecast performance – the better living standards the brighter VDS prospects
Vitamins in will lead on, but slightly
Dietary supplements fits diverse needs
Child-specific vitamins and dietary supplements benefits from diversification trend
Tonics and bottled nutritive drinks in bad need of promotion
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Summary 13 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 53 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
Vitamins – a strong appeal with health image
Multivitamins – indisputable leader
Single vitamins
Vitamin C – help to combat colds, please
Specific effects targeted determine sales value of single vitamins
Multinationals lead with strong presence in multivitamins
Table 54 Sales of Vitamins by Type: Value 2000-2005
Table 55 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 56 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Dietary supplements still unstructured
Ginkgo biloba on the wave of popularity – eagerness to get smarter brings smarter results
Calcium and mineral supplements face multivitamins competition
Fish oils largely bought for children
Ginseng and Echinacea excellent for strengthening immunity
A number of negligible niches awaiting development
Eye health supplements
Other dietary supplements diverse – too many products make customers puzzled
Shares fragmented – too many players and weak brands’ positioning
Table 57 Sales of Dietary Supplements by Type: Value 2000-2005
Table 58 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 59 Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 60 Dietary Supplements by Positioning: % Retail Value Analysis 2005
NRT SMOKING CESSATION AIDS IN UKRAINE
NUMBER OF SMOKERS
Table 61
SECTOR PERFORMANCE
2005 headlines
2005 sales slow – little of legal developments characterises the sector
NRT gum – the only active subsector in 2005
Lack of assortment means a number of negligible subsectors
Uncompetitive environment does not promote NRT smoking cessation aids
Future performance determined by economic and social factors
NRT gum determines forecast sales
Table 62 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 63 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 64 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 65 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 66 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 67 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
EYE CARE IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
2005 value sales performance speeds up on the previous year
Standard eye care determines the sector performance in 2005
Value pace more dynamic than volume sales increase – unit price is slightly up in 2005
Multinationals dominate – high unit price results in value sales priority position
Forecast performance dependent on legislative regulations
Main factors stimulating eye care
Convenience and proper positioning in stores traditionally important
Table 68 Sales of Eye Care by Subsector: Value 2000-2005
Table 69 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 70 Eye Care Company Shares by Retail Value 2001-2005
Table 71 Eye Care Brand Shares by Retail Value 2002-2005
Summary 14 Summary - Eye Care: New Product Launches 2004-2005
Table 72 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 73 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN UKRAINE
SECTOR PERFORMANCE
Ear care squeezed by Rx medicines
Biocodex beats with high unit price
Ear care slows with saturation unless switching becomes active
ADULT MOUTHCARE IN UKRAINE
SECTOR PERFORMANCE
Adult mouthcare faces competition from toothpastes innovative launches
Leaders’ positions stable
Innovations required to boost consumer interest
CALMING AND SLEEPING PRODUCTS IN UKRAINE
SECTOR PERFORMANCE
Calming and sleeping products determined by lifestyles and incomes
Herbal-based products particularly appealing
Foreign companies lead in value sales while locals beat with volumes
Forecast period promising – positive factors converge
WOUND TREATMENTS IN UKRAINE
SECTOR PERFORMANCE
2005 headlines
Wound treatments improves on 2004 – rising prices drive value sales ahead
Sticking plasters – the highest growth subsector in 2005
Unit price grows in 2005 – value sales overtakes volume performance
Other wound treatments suffers from lack of developments
Leadership firmly established
Forecast performance restricted by the sector’s maturity level
Sticking plasters – the most dynamic forecast growth
Other wound treatments keeps on declining in value terms
Table 74 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 75 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 76 Wound Treatments Company Shares by Retail Value 2001-2005
Table 77 Wound Treatments Brand Shares by Retail Value 2002-2005
Summary 15 Summary - Wound Treatments: New Product Launches 2004-2005
Table 78 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 79 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN UKRAINE
SECTOR PERFORMANCE